Introduction
Recently, the application of particle accelerators to medicine, materials science, and other industrial uses has increased dramatically. A random sampling of some of these new programs is discussed here, primarily to give the scope of these new applications. This survey is certainly not meant to be exhaustive, and any omissions are regretted. The three areas, medicine, materials science or solid-state physics, and industrial applications, are chosen for their diversity and are representative of new accelerator applications for the future.
New Applications in Medicine
Historically, the application of accelerators to medicine occurred almost simultaneously with the invention of accelerators themselves, as Roentgen rays were used for medical x-ray purposes almost as soon as they were discovered. Recently, the application of accelerator technology to the generation of more exotic radiations for cancer therapy has been at the leading edge of radiotherapy research. Pi mesons, heavy ions, and neutrons are being applied to various tumor types with varying degrees of success Figure 1 shows the beam layout at SIN, which allows this beam-sharing mode of operation.
The pion delivery system at SIN uses a modified version of the superconducting "Orange Peel" spectrometer, first suggested and later constructed and tested by the Stanford University High Energy Physics Laboratory group for this purpose. In this system, a very large overall fraction of the produced pi mesons is accepted by forming 60 independent "beamlets," all with a common origin and a common focal point. Solidangle acceptances of up to 1 sr with momentum acceptances of <3% are possible with such a system. Figure 2 shows the layout of the SIN "PIOTRON." Although the accurate delivery of 60 pion beams may seem a formidable task, SIN has made good progress on solving this problem. Initially, the pion channels will be tuned to the same momentum. The patient's tumor is scanned with the beam-stopping radiation peak by mechanically moving the patient within a water bolus to cover the treatment volume uniformly. Future The second new pion therapy program has been initiated at the TRIUMF facility in Vancouver, British Columbia, Canada. The TRIUMF cyclotron is a negative-ion cyclotron with a proton current of approximately 100 pA at a peak energy of 480 MeV. In the case of the TRIUMF accelerator, the entire proton beam is used for pion generation, and as in the case of LAMPF, multiple-beam lines view the same target. Figure 3 shows the pion beam channel layout at the TRIUMF facility. The pion collection channel used for this facility is of conventional construction, with a chain of conventional bending and quadrupole magnets collecting and purifying the beam for direction to the tumor volume. The system performance allows a peak-dose rate of approximately 20 rads/min in a small volume, and a large field-dose rate of approximately 4 rads/min/liter with a 15-cm stopping width. Eight patients with multiple small skin-nodule tumors have been treated to date. The first treatments were undertaken in December 1979. Several facility improvements are planned in the next year or so, including an increased current capability and inclusion of a permanent magnet-quadrupole very near the target location. Adding a SIN-type superconducting collection system is being considered.
Coupled with the ongoing pion therapy program at Los Alamos, which has treated 150 patients so far and has started phase III clinical trials (randomized patient selection and tumor stages amenable to therapeutic treatment), these new facilities will soon give a clear picture of the efficacy of pion therapy in the control of malignant tumors. Many initial signs point to important contributions from these-programs. At Los Alamos, the accelerator development required to make pion therapy possible in a hospital environment has progressed dramatically in the PIGMI program, funded by the National Cancer Institute. With the successful demonstration of the radio-frequency quadrupole accelerator system, a clear route to making a linear accelerator system both economically feasible and compatible in size with a hospital installation has been demonstrated. The accelerator community is prepared to satisfy the medical requirements to make widespread pion therapy a possibility, if the ongoing trials continue to be successful. Neutron diffraction can be used to examine structural questions in a fashion similar to x-ray diffraction. However, the neutron interacts most strongly with the nucleus rather than the electron, so that its scattering cross section is such that neutron diffraction often provides unique information regarding crystal or molecular structure. Neutrons The main technical problem associated with this source is particle loss and the resultant activation of the accelerator components. The intensity of 2.5 x l013 protons per pulse is essentially the space-charge limit for the ring at injection energy; very careful tailoring of emittance on injection will be required to limit beam spill.
Construction is well under way at Rutherford. The injector linac is the old PLA rebuilt for this repetition rate. Figure 4 shows the layout of the SNS. The entire facility is located in the building complex that housed the NIMROD accelerator, which was decommissioned in 1976. It is now expected that the SNS As with the SNS synchrotron, beam loss is a major technical problem to be considered in the design of this source. Special attention has been paid to beam loss in the beam-extraction system to minimize activation. The PSR also operates in a short-pulse mode for fast neutron time-of-flight measurements, and will be used for both materials science and fastneutron physics. Figure 5 shows the plan view of the PSR. in future fusion reactors. FMIT will be, when completed, the highest current ion linear accelerator ever built. Some parameters of the FMIT accelerator are listed below.
Construction of the PSR has been started, and completion is projected for 1985. The overall project involves modifying LAMPF for a high-current H-beam, building the storage ring, and upgrading the neutron-source target for high-average power. project and the operation of a 5-MeV prototype are the responsibility of the Los Alamos National Laboratory. The prototype is more than half complete, and operation is expected in 1982. Completion of the FMIT facility is expected in 1985.
An interesting feature of the accelerator combines a low-voltage injector and a radio-frequency quadrupole accelerator system to provide injection into the drift-tube linac. The radio-frequency quadrupole design tube captures 95% of a direct-current 75-kV ion beam, bunches this beam, and accelerates it to the required 2 MeV. The beam's target is unique; it must dissipate 3.5 MW of beam power while providing a very high conversion from deuterons to fast neutrons. The liquid-metal coolant technology developed for fast-reactor systems will be adapted to provide a windowless flowing lithium target for this neutron production. Figure 6 shows a layout of the FMIT accelerator system with beam transport to two target stations.
New ADplications in Industry
The design of this accelerator is conventional except for the focusing system, which uses for the first time, in a linear ion accelerator, permanent magnets located inside the drift tubes of the resonant radio-frequency cavity. This is a significant advance in accelerator technology and should result in a reliable and elegant system for this industrial use. First operation of the NEN linac is expected in about one year The energy is chosen to optimize the production of 201T1, an isotope now in very great demand for medical applications.
In conclusion, I can only point out that I have barely scratched the surface of new applications of particle accelerators. Many lower energy machines are being used for medical diagnosis and therapy, in solid-state physics, and in industrial applications, and are now making a significant contribution to our gross industrial output. I believe the next decade will see further substantial use of accelerator technology in fields far from those where this technology was first developed.
The New England Nuclear Company has undertaken the construction of a very large proton linear accelerator for the commercial production of radioactive isotopes for its customers. Some parameters for this accelerator include the following. 
